Xiangzhong Xue

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 3

Top Topics

Drug Administration

Chronic Lymphocytic Leukemia

Monoclonal Antibody

Childhood Cancer

Top Venues

Expert opinion on drug safety

Expert opinion on biological therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Xiangzhong Xue, Jingjing Qian
Safety of marketed biosimilar monoclonal antibody cancer treatments in the US: a disproportionality analysis using the food and drug administration adverse event reporting system (FAERS) database. Expert opinion on drug safety (2024)
Xiangzhong Xue, Jingjing Qian
Safety of marketed biosimilar monoclonal antibody cancer treatments in the US: a disproportionality analysis using the food and drug administration adverse event reporting system (FAERS) database. Expert opinion on drug safety (2024)
Xiangzhong Xue, Cong Bang Truong, Jingjing Qian
Adverse event reporting of marketed biosimilar and biological monoclonal antibody cancer treatments in the United States. Expert opinion on biological therapy (2023)